Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes
Status:
Recruiting
Trial end date:
2023-05-10
Target enrollment:
Participant gender:
Summary
Trial Design: This is a 12 week randomised controlled open label trial comparing the impact
of Dapagliflozin, Metformin and combination therapy on vascular function in newly diagnosed
T2DM patients.